EXPLORE CONNECTIONS
A double-blind multicentre study comparing remoxipride, controlled release formulation, with haloperidol in schizophrenia.
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.